US Bancorp’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.25K | Buy |
975
+44
| +5% | +$102 | ﹤0.01% | 3841 |
|
|
2025
Q1 | $1.29K | Buy |
931
+203
| +28% | +$282 | ﹤0.01% | 3929 |
|
|
2024
Q4 | $1.26K | Sell |
728
-132
| -15% | -$228 | ﹤0.01% | 3923 |
|
|
2024
Q3 | $1.73K | Sell |
860
-15,217
| -95% | -$30.6K | ﹤0.01% | 3801 |
|
|
2024
Q2 | $36K | Sell |
16,077
-1,561
| -9% | -$3.5K | ﹤0.01% | 2818 |
|
|
2024
Q1 | $50.6K | Buy |
+17,638
| New | +$50.6K | ﹤0.01% | 2682 |
|
|
2022
Q1 | – | Sell |
-524
| Closed | -$6K | – | 4162 |
|
|
2021
Q4 | $6K | Buy |
+524
| New | +$6K | ﹤0.01% | 3576 |
|